Skip to content

Clinical research study of Soothaga vaayu leghium and Veezhi ennei (Internal medicines)in the treatment of Garpa vaayu (polycystic ovarian disease)

Clinical study on Garpa vaayu (polycystic ovarian disease) and the drug of choice is Soothaga vaayu leghium and Veezhi ennei.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/01/004282
Enrollment
40
Registered
2014-01-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- GARPA VAAYU(POLYCYSTIC OVARIAN DISEASE)

Interventions

Intervention1: SOOTHAGA VAAYU LEGHIUM WITH VEEZHI ENNAI: 70 ml of VEEZHI ENNAI will be administered orally before food as a single dosage for the first three days of every menstrual cycle for the c

Sponsors

AYOTHIDOSS PANDITHAR HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Age: 16-35 years •Patient having the symptoms of irregular menstruation •Oligomenorrhoea (or) Amenorrhoea (or) Dysmenorrhoea •Patient willing to take USG pelvis •Patient willing to undergo routine blood investigation. •USG pelvis showing polycystic ovaries •Patient willing to undergo purgation as a preparatory part of treatment •Patient willing to participate in trial and signing in consent form

Exclusion criteria

Exclusion criteria: • H/O hypertension • H/O diabetes mellitus • H/O cardiac disease • Pregnancy and lactation • H/O thyroid dysfunction • H/O recent hormone therapy (Past one year)

Design outcomes

Primary

MeasureTime frame
assessed by the improvement in the score of irregular menstruation (Intermenstrual period& duration of bleeding)Timepoint: pre study screening and after treatment

Secondary

MeasureTime frame
Changes in the polycystic swellings of the ovaries in USG pelvis and reduction of other clinical symptomsTimepoint: pre study screening and after treatment

Countries

India

Contacts

Public ContactDR H NALINI SOFIA

NATIONAL INSTITUTE OF SIDDHA

dr.kmvm@gmail.com044-22411611

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026